1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
GLOBAL JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030

GLOBAL JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030

  • November 2021
  • 206 pages
  • ID: 6187333
  • Format: PDF
  • Inkwood Research

Summary

Table of Contents

KEY FINDINGS
The global joint pain injections market is anticipated to register a CAGR of 8.56% during the forecast years of 2022 to 2030. The market growth is attributable to key drivers such as the increased prevalence of bone and joint-related diseases across the geriatric population, the increasing number of sports injuries, and the rising incidence of musculoskeletal disorders.

MARKET INSIGHTS
Joint pain injections are medicinal fluids introduced into the patient’s body in order to facilitate faster relief from severe pain.They are utilized to reduce inflammation in the joints.

Several types of injections available in the market include corticosteroids injections, platelet-rich plasma (PRP) injections, hyaluronic acid (HA) injections, as well as placental tissue matrix (PTM) injections.
Musculoskeletal disorders (MSDs) entail medical conditions impacting muscles, bones, and joints of the shoulders, neck, wrists, hips, legs, back, knees, and feet.These diseases include tendinitis, osteoarthritis, carpal tunnel syndrome, rheumatoid arthritis (RA), bone fractures, and fibromyalgia.

According to the World Health Organization (WHO) factsheet updated in 2021, around 1.71 billion people have musculoskeletal conditions globally. Moreover, among musculoskeletal disorders, low back pain represents the highest burden, prevalent in approximately 568 million people. The high incidence of musculoskeletal disorders in different countries increases the number of treatment procedures conducted for the same, thus fueling the global joint pain injections market growth.

REGIONAL INSIGHTS
The global joint pain injections market growth evaluation comprises the assessment of Asia-Pacific, North America, Europe, and Rest of World.North America held the highest revenue share in 2021.

The region’s market growth is primarily facilitated by the augmenting demand for advanced therapeutic platforms to enhance treatment outcomes and the rising number of new product launches and approvals.

COMPETITIVE INSIGHTS
The competition among tier 1 companies as well as tier 2 and tier 3 companies in the global joint pain injections market is increasing.Moreover, the threat of rivalry is high among market players within their respective segments.

Vendors also differentiate their products on the basis of quality, cost, and application.
Some of the top firms operating in the market are Allergan PLC, Sanofi, Pfizer Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ALLERGAN PLC (ACQUIRED BY ABBVIE)
2. ANIKA THERAPEUTICS INC
3. BIOVENTUS INC
4. CHUGAI PHARMACEUTICAL
5. FERRING PHARMACEUTICALS
6. FIDIA PHARMA USA INC
7. FLEXION THERAPEUTICS INC
8. ORTHOGENRX INC
9. PFIZER INC
10. SANOFI
11. SEIKAGAKU CORPORATION
12. SMITH & NEPHEW PLC
13. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
14. ZIMMER BIOMET HOLDINGS

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Fibromyalgia (Fibromyalgia Syndrome) - Global Clinical Trials Review, H2, 2021

  • $ 2500
  • December 2021
  • 327 pages

Fibromyalgia (Fibromyalgia Syndrome) - Global Clinical Trials Review, H2, 2021 Summary clinical trial report, “Fibromyalgia (Fibromyalgia Syndrome) - Global Clinical Trials Review, H2, 2021" provides ...

  • World
  • Chronic Pain
  • Clinical Trial
  • Industry analysis
  • Elderly Population
  • Diagnostic Imaging Density

ref:plp2021

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on